KR20230004568A - 주사 가능한 유성 약제학적 조성물 - Google Patents

주사 가능한 유성 약제학적 조성물 Download PDF

Info

Publication number
KR20230004568A
KR20230004568A KR1020227038860A KR20227038860A KR20230004568A KR 20230004568 A KR20230004568 A KR 20230004568A KR 1020227038860 A KR1020227038860 A KR 1020227038860A KR 20227038860 A KR20227038860 A KR 20227038860A KR 20230004568 A KR20230004568 A KR 20230004568A
Authority
KR
South Korea
Prior art keywords
particles
agents
coated
core
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227038860A
Other languages
English (en)
Korean (ko)
Inventor
앤더스 요한슨
마르텐 루쓰
요엘 헬럽
Original Assignee
나넥사 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나넥사 에이비 filed Critical 나넥사 에이비
Publication of KR20230004568A publication Critical patent/KR20230004568A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020227038860A 2020-04-17 2021-04-16 주사 가능한 유성 약제학적 조성물 Pending KR20230004568A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2005593.5A GB202005593D0 (en) 2020-04-17 2020-04-17 New composition
GB2005593.5 2020-04-17
PCT/GB2021/050913 WO2021209762A1 (en) 2020-04-17 2021-04-16 Injectable oil-based pharmaceutical composition

Publications (1)

Publication Number Publication Date
KR20230004568A true KR20230004568A (ko) 2023-01-06

Family

ID=70860026

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227038860A Pending KR20230004568A (ko) 2020-04-17 2021-04-16 주사 가능한 유성 약제학적 조성물

Country Status (9)

Country Link
US (1) US20230157968A1 (cg-RX-API-DMAC10.html)
EP (1) EP4135672A1 (cg-RX-API-DMAC10.html)
JP (1) JP7883442B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230004568A (cg-RX-API-DMAC10.html)
CN (1) CN116075295A (cg-RX-API-DMAC10.html)
AU (1) AU2021256075A1 (cg-RX-API-DMAC10.html)
CA (1) CA3179556A1 (cg-RX-API-DMAC10.html)
GB (1) GB202005593D0 (cg-RX-API-DMAC10.html)
WO (1) WO2021209762A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023105227A1 (en) * 2021-12-08 2023-06-15 Nanexa Ab New injectable combination formulation
GB2619556A (en) * 2022-06-10 2023-12-13 Nanexa Ab New process
AU2023392764A1 (en) * 2022-12-15 2025-06-19 Nanexa Ab New pharmaceutical compositions comprising glucagon-like peptide-1 receptor agonists
GB202218958D0 (en) 2022-12-15 2023-02-01 Nanexa Ab New pharmaceutical composition
CN117844877B (zh) * 2024-01-14 2024-09-06 宿州市东凯医药科技有限公司 一种通过生物酶制备普瑞巴林的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097742B2 (en) 2005-01-20 2012-01-17 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
EP3685837A1 (en) * 2008-09-04 2020-07-29 Amylin Pharmaceuticals, LLC Sustained release formulations using non-aqueous carriers
KR102264011B1 (ko) 2013-05-24 2021-06-10 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자

Also Published As

Publication number Publication date
WO2021209762A1 (en) 2021-10-21
US20230157968A1 (en) 2023-05-25
JP7883442B2 (ja) 2026-07-01
GB202005593D0 (en) 2020-06-03
JP2023522056A (ja) 2023-05-26
CA3179556A1 (en) 2021-10-21
AU2021256075A1 (en) 2022-11-03
CN116075295A (zh) 2023-05-05
EP4135672A1 (en) 2023-02-22

Similar Documents

Publication Publication Date Title
US11214865B2 (en) Apparatus for coating particles
JP7733651B2 (ja) 新規組成物
US20230157968A1 (en) Injectable oil-based pharmaceutical composition
JP7828278B2 (ja) 医薬組成物の製造のための新規プロセス
US20250041208A1 (en) New injectable combination formulation
GB2594083A (en) New composition
KR20250022795A (ko) 약학적 조성물의 제조를 위한 기상 증착 기술
CN118647367A (zh) 新颖可注射组合制剂
US20240261228A1 (en) New process
WO2024127018A1 (en) New injectable suspension of coated particles

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902